Back to Search Start Over

Blood pressure control in hypertensive sleep apnoea patients of the European Sleep Apnea Database cohort - effects of positive airway pressure and antihypertensive medication.

Authors :
Svedmyr, Sven
Hedner, Jan
Bailly, Sebastien
Fanfulla, Francesco
Hein, Holger
Lombardi, Carolina
Ludka, Ondrej
Mihaicuta, Stefan
Parati, Gianfranco
Pataka, Athanasia
Schiza, Sophia
Tasbakan, Sezai
Testelmans, Dries
Zou, Ding
Grote, Ludger
European Sleep Apnea Database (ESADA) study group
P, Steiropoulos
J, Verbraecken
E, Petiet
Trakada, Georgia
Source :
European Heart Journal Open; Nov2023, Vol. 3 Issue 6, p1-10, 10p
Publication Year :
2023

Abstract

Aims: We analysed longitudinal blood pressure (BP) data from hypertensive obstructive sleep apnoea (OSA) patients in the European Sleep Apnea Database cohort. The study investigated the interaction between positive airway pressure (PAP)-induced BP change and antihypertensive treatment (AHT). Methods and results: Hypertensive patients with AHT [monotherapy/dual therapy n = 1283/652, mean age 59.6 ± 10.7/60.6 ± 10.3 years, body mass index (BMI) 34.2 ± 6.5/34.8 ± 7.0 kg/m<superscript>2</superscript>, apnoea–hypopnoea index 46 ± 25/46 ± 24 n/h, proportion female 29/26%, respectively] started PAP treatment. Office BP at baseline and 2- to 36-month follow-up were assessed. The interaction between AHT drug classes and PAP on BP was quantified and the influences of age, gender, BMI, co-morbidities, BP at baseline, and study site were evaluated. Following PAP treatment (daily usage, 5.6 ± 1.6/5.7 ± 1.9 h/day), systolic BP was reduced by −3.9 ± 15.5/−2.8 ± 17.7 mmHg in mono/dual AHT and diastolic BP by −3.0 ± 9.8/−2.7 ± 10.8 mmHg, respectively, all P < 0.0001. Systolic and diastolic BP control was improved following PAP treatment (38/35% to 54/46% and 67/67% to 79/74%, mono/dual AHT, respectively). PAP treatment duration predicted a larger BP improvement in the monotherapy group. Intake of renin–angiotensin blockers [angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB)] alone or in any AHT combination was associated with better BP control. The AHT-dependent BP improvement was independent of confounders. Conclusion: In this pan-European OSA patient cohort, BP control improved following initiation of PAP. Longer PAP treatment duration, was associated with a favourable effect on BP. Our study suggests that ACEI/ARB, alone or in combination with other drug classes, provides a particularly strong reduction of BP and better BP control when combined with PAP in OSA. Graphical Abstract [ABSTRACT FROM AUTHOR]

Details

Language :
English
Volume :
3
Issue :
6
Database :
Complementary Index
Journal :
European Heart Journal Open
Publication Type :
Academic Journal
Accession number :
174784117
Full Text :
https://doi.org/10.1093/ehjopen/oead109